Jeffrey S. Sabol

1.2k total citations
24 papers, 961 citations indexed

About

Jeffrey S. Sabol is a scholar working on Organic Chemistry, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Jeffrey S. Sabol has authored 24 papers receiving a total of 961 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Organic Chemistry, 9 papers in Molecular Biology and 8 papers in Pharmaceutical Science. Recurrent topics in Jeffrey S. Sabol's work include Fluorine in Organic Chemistry (8 papers), Carbohydrate Chemistry and Synthesis (8 papers) and Chemical Synthesis and Analysis (7 papers). Jeffrey S. Sabol is often cited by papers focused on Fluorine in Organic Chemistry (8 papers), Carbohydrate Chemistry and Synthesis (8 papers) and Chemical Synthesis and Analysis (7 papers). Jeffrey S. Sabol collaborates with scholars based in United States. Jeffrey S. Sabol's co-authors include David R. Borcherding, Philip M. Weintraub, John M. Kane, James R. McCarthy, C He, T. Mitsuhashi, Helen Vlassara, Robert J. Cregge, Donald P. Matthews and Gary A. Flynn and has published in prestigious journals such as Diabetes, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Jeffrey S. Sabol

23 papers receiving 898 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey S. Sabol United States 13 694 264 155 141 103 24 961
Christer Westerlund Sweden 15 444 0.6× 243 0.9× 20 0.1× 15 0.1× 47 0.5× 31 837
Mustafa Adiyaman United States 13 412 0.6× 202 0.8× 16 0.1× 27 0.2× 28 0.3× 19 864
Louis Freedman United States 16 352 0.5× 230 0.9× 27 0.2× 25 0.2× 59 0.6× 58 742
Moses J. Namkung United States 19 74 0.1× 330 1.3× 70 0.5× 47 0.3× 21 0.2× 62 947
L. A. Damani United Kingdom 14 111 0.2× 180 0.7× 35 0.2× 46 0.3× 17 0.2× 54 618
Conrad Santini United States 17 408 0.6× 493 1.9× 43 0.3× 11 0.1× 46 0.4× 30 883
Eiji Ohki United Kingdom 15 431 0.6× 268 1.0× 30 0.2× 18 0.1× 15 0.1× 88 743
Barry C. Ross United Kingdom 16 372 0.5× 505 1.9× 165 1.1× 11 0.1× 48 0.5× 38 905
Justin M. Lopchuk United States 13 804 1.2× 387 1.5× 92 0.6× 10 0.1× 85 0.8× 26 1.2k
Bernard Hulin United States 15 339 0.5× 307 1.2× 22 0.1× 10 0.1× 46 0.4× 23 645

Countries citing papers authored by Jeffrey S. Sabol

Since Specialization
Citations

This map shows the geographic impact of Jeffrey S. Sabol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey S. Sabol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey S. Sabol more than expected).

Fields of papers citing papers by Jeffrey S. Sabol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey S. Sabol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey S. Sabol. The network helps show where Jeffrey S. Sabol may publish in the future.

Co-authorship network of co-authors of Jeffrey S. Sabol

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey S. Sabol. A scholar is included among the top collaborators of Jeffrey S. Sabol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey S. Sabol. Jeffrey S. Sabol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Liang, Daniel McGarry, Frank Volz, et al.. (2004). Synthesis and SAR of novel 4,5-diarylimidazolines as potent P2X7 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 15(2). 435–438. 42 indexed citations
2.
Weintraub, Philip M., Jeffrey S. Sabol, John M. Kane, & David R. Borcherding. (2003). Recent advances in the synthesis of piperidones and piperidines. Tetrahedron. 59(17). 2953–2989. 409 indexed citations
3.
Weintraub, Philip M., Jeffrey S. Sabol, John M. Kane, & David R. Borcherding. (2003). Recent Advances in the Synthesis of Piperidones and Piperidines. ChemInform. 34(27). 1 indexed citations
4.
Borcherding, David R., et al.. (2001). A stereocontrolled approach to substituted piperidones and piperidines: flavopiridol D-ring analogs. Tetrahedron Letters. 42(9). 1631–1633. 22 indexed citations
5.
He, C, Jeffrey S. Sabol, T. Mitsuhashi, & Helen Vlassara. (1999). Dietary glycotoxins: inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration.. Diabetes. 48(6). 1308–1315. 161 indexed citations
6.
McCarthy, James R., et al.. (1998). Terminal Fluoroolefins. The Synthesis of Novel Carboacyclic Nucleosides. Nucleosides and Nucleotides. 17(6). 1099–1113. 4 indexed citations
7.
Sabol, Jeffrey S., Gary A. Flynn, Dirk Friedrich, & Edward W. Huber. (1997). Constrained amino acids. The synthesis of glutamine mimetics. Tetrahedron Letters. 38(21). 3687–3690. 15 indexed citations
8.
Flynn, Gary A., et al.. (1996). Constrained amino acids. An approach to the synthesis of 3-substituted prolines. Tetrahedron Letters. 37(24). 4091–4094. 39 indexed citations
9.
EDWARDS, M. L., David M. Stemerick, Jeffrey S. Sabol, Keith A. Diekema, & Robert J. Dinerstein. (1994). Inhibition of Myeloperoxidase Release from Rat Polymorphonuclear Leukocytes by a Series of Azachalcone Derivatives. Journal of Medicinal Chemistry. 37(25). 4357–4362. 20 indexed citations
10.
Matthews, Donald P., et al.. (1994). The synthesis of (1-fluorovinyl)tributyltin: A synthetic equivalent for the 1-fluoroethene anion. Tetrahedron Letters. 35(29). 5177–5180. 23 indexed citations
11.
Sabol, Jeffrey S. & Ian A. McDonald. (1994). Fluorinated amino acids Part 2: Synthesis of diastereomeric N-acyloxazolidinone precursors. Tetrahedron Letters. 35(12). 1817–1820. 2 indexed citations
12.
Sabol, Jeffrey S., et al.. (1994). Fluorinated amino acids Part 3: Synthesis of β-difluoromethyl--tyrosine. Tetrahedron Letters. 35(12). 1821–1824. 5 indexed citations
13.
Matthews, Donald P., et al.. (1993). A new method for the electrophilic fluorination of vinyl stannanes.. Tetrahedron Letters. 34(19). 3057–3060. 58 indexed citations
14.
McDonald, Ian A., et al.. (1991). Syntheses of -2-fluoromethy--tyrosine and -2-difluoromethyl--tyrosine as potential inhibitors of tyrosine hydroxylase. Tetrahedron Letters. 32(7). 887–890. 18 indexed citations
15.
Cregge, Robert J., et al.. (1991). Conformationally restricted leukotriene antagonists. Synthesis of chiral 4-hydroxy-4-alkylcyclohexanecarboxylic acids as leukotriene D4 analogs. The Journal of Organic Chemistry. 56(5). 1758–1763. 4 indexed citations
16.
Sabol, Jeffrey S., et al.. (1990). MDL 28,753, an agonist of LTD4 but an antagonist of LTC4 in longitudinal muscle of guinea pig ileum.. Journal of Pharmacology and Experimental Therapeutics. 254(1). 192–197. 5 indexed citations
17.
18.
Sabol, Jeffrey S. & Robert J. Cregge. (1990). Conformationally restricted leukotriene antagonists. Asymmetric synthesis of a nor-leokotriene D4 analog. II.. Tetrahedron Letters. 31(1). 27–30. 11 indexed citations
19.
Sabol, Jeffrey S., et al.. (1990). Conformationally restricted leukotriene antagonists. Stereoselective synthesis of some leukotriene D4 analogs. Tetrahedron. 46(12). 4155–4160. 2 indexed citations
20.
Sabol, Jeffrey S. & Robert J. Cregge. (1989). Conformationally restricted leukotriene antagonists. Synthesis of some leukotriene D4 analogs from D-xylose. Tetrahedron Letters. 30(46). 6271–6274. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026